Mutational analysis of the BRCA1 tumor suppressor gene in endometrial carcinoma

Gynecologic Oncology

Volumn 66, Issue 3, 1997, Pages 449-453

  Liu, Fu Shing ^a   Ho, Esther Shih Chu ^a   Shih, Rocky Tai Ping ^a   Shih, Ai ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ONCOPROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; DNA SEQUENCE; ELECTROPHORETIC MOBILITY; ENDOMETRIUM CARCINOMA; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0031239955     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4800     Document Type: Article

References (34)

1. 1. Enomoto T, Inoue M, Peratoni AO, Buzard GS, Miki H, Tanizawa O, Rice J: K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Res 51:5308-5314, 1991
2. 2. Sasaki H, Nishii H, Takahashi H, Tada A, Furusato M, Terashima Y, Siegal GP, Parker SL, Kohler MF, Berchuck A, Boyd J: Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res 53:1906-1910, 1993
3. 3. Berchuck A, Rodriguez G, Kinney RB, Soper JT, Dodge RK, Clarke-Pearson DL, Bast RC Jr: Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am J Obstet Gynecol 164:15-21, 1991
4. 4. Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC: HER-2/neu expression: a major prognostic factor in endometrial carcinoma. Gynecol Oncol 47:179-185, 1992
5. 5. Okamoto A, Sameshima Y, Yamada Y, Teshima S-i, Terashima Y, Terada M, Yokota J: Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus. Cancer Res 51:5632-5636, 1991
6. 6. Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR: Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 52:1622-1627, 1992
7. 7. Gima T, Kato H, Honda T, Imamura T, Sasazuki T, Wake N: DCC gene alteration in human endometrial carcinomas. Int J Cancer 57:480-485, 1994
8. 8. Yamada H, Sasaki M, Honda T, Wake N, Boyd J, Oshimura M, Barrett JC: Suppression of endometrial carcinoma cell tumorigenicity by human chromosome 18. Genes Chromosomes Cancer 13:18-24, 1995
9. 9. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnicj MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994
10. 10. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R: BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122, 1994
11. 11. Eastern DF, Bishop T, Ford D, Crockford GP, Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52:678-701, 1993
12. 12. Hosking L, Trowsdale J, Nicolai H, Solomon E, Foulkes W, Stamp G, Signer E, Jeffreys A: A somatic BRCA1 mutation in an ovarian tumour. Nature Genet 9:343-344, 1995
13. 13. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS: Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet 9:439-443, 1995
14. 14. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet 9:444-450, 1995
15. 15. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, Breast Cancer Linkage Consortium: Risks of cancer in BRCA1-mutation carriers. Lancet 343:692-695, 1994
16. 16. Gao X, Zacharek A, Salkowski A, Grignon DJ, Sakr W, Porter AT, Honn KV: Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 55:1002-1005, 1995
17. 17. Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC, Collins FS, Weber BL: Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet 8:387-391, 1994
18. 18. Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King M-C: Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet 8:399-404, 1994
19. 19. Thompson WD: Genetic epidemiology of breast cancer. Cancer 74(1 Suppl):279-287, 1994
20. 20. Schoen RE, Weissfeld JL, Kuller LH: Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer? Am J Gastroenterol 89:835-842, 1994
21. 21. Anderson DE, Badzioch MD: Familial effects of prostate and other cancers on lifetime breast cancer risk. Breast Cancer Res Treat 28:107-113, 1993
22. 22. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of ther HER-2/neu oncogene. Science 235:177-182, 1987
23. 23. Wright C, Angus B, Nicholson S, Sainsbury JRC, Cairns J, Gullick WJ, Kelly P, Harris AL, Wilson Home CH: Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 49:2087-2090, 1989
24. 24. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712, 1989
25. 25. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P, McKenzie S, Yin S, Bast RC Jr: Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50:4087-4091, 1990
26. 26. Kuhn EJ, Kurnot RA, Sesterhenn IA, Chang EH, Moul JW: Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma. J Urol 150(5 Pt 1):1427-1433, 1993
27. 27. Davidoff AM, Humphrey PA, Iglehart JD, Marks JR: Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 88:5006-5010, 1991
28. 28. Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC Jr, Berchuck A: Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51:2979-2984, 1991
29. 29. Chi SG, deVere-White RW, Meyers FJ, Siders DB, Lee F, Gumerlock PH: p53 in prostate cancer: frequent expressed transition mutations. J Natl Cancer Inst 86:926-933, 1994
30. 30. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217-221, 1989
31. 31. Thompson AM, Morris RG, Wallace M, Wyllie AH, Steel CM, Carter DC: Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 68:64-68, 1993
32. 32. Enomoto T, Fujita M, Cheng C, Nakashima R, Ozaki M, Inoue M, Nomura T: Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Br J Cancer 71:462-467, 1995
33. 33. Gao X, Honn KV, Grignon D, Sakr W, Chen YQ: Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res 53:2723-2727, 1993
34. 34. Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ, Weber BL, Chodosh LA: The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nature Genet 11:17-26, 1995